Revelation Biosciences
(NASDAQ) REVB
Revelation Biosciences Financials at a Glance
Market Cap
$4.43M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.91M
EPS (TTM)
$-62.10
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$1.19
Volume
33,394
Open
$1.18
Price
$1.19
Volume
33,394
Open
$1.18
Previous Close
$1.19
Daily Range
$1.17 - $1.23
52-Week Range
$1.14 - $44.77
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$1.19
Volume
33,394
Open
$1.18
Previous Close
$1.19
Daily Range
$1.17 - $1.23
52-Week Range
$1.14 - $44.77
REVB News
REVB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Revelation Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
James M. Rolke
Website
www.revbiosciences.comHeadquarters
San Diego, CA 92122, US
REVB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-131%
Return on Capital
-0%
Return on Assets
-0%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
-667.69%
Stock Overview
Market Cap
$4.43M
Shares Outstanding
3.72M
Volume
33.39K
Short Interest
0.00%
Avg. Volume
654.85K
Financials (TTM)
Gross Profit
$27.06K
Operating Income
$9.07M
EBITDA
$18.14M
Operating Cash Flow
$8.27B
Capital Expenditure
$0.00
Free Cash Flow
$8.27B
Cash & ST Invst.
$10.70B
Total Debt
$746.78M
Revelation Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$5.85K
-143.4%
Gross Margin
0.00%
N/A
Market Cap
$4.43M
N/A
Market Cap/Employee
$553.41K
N/A
Employees
8
N/A
Net Income
$2.51M
-45.5%
EBITDA
$24.53M
+1504.2%
Quarterly Fundamentals
Net Cash
$9.95B
+153054.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$723.77M
N/A
Short Term Debt
$23.01M
N/A
Return on Assets
-0.08%
N/A
Return on Invested Capital
-0.09%
N/A
Free Cash Flow
$1.97M
+47.3%
Operating Cash Flow
$1.97M
+47.5%